In recent years, scientific advancements have transformed our understanding of diseases, particularly at the cellular level.
KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...
Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...
Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...
Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and ...
Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...
Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering at KAIST has captured the critical ...
New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.
The research team led by Professor Kwang-Hyun Cho of KAIST Bio and Brain Engineering who recently announce "Cancer Reversion ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...